01 2DARMERICA, LLC
02 1Hangzhou Sinodo Pharm Technology Co.,Ltd
03 1Qingdao Biopeptek Co., Ltd.
01 2Thymosin Beta 4 Acetate
02 1Thymosin Beta-4 Acetate
03 1Thymosin Beta-4 Fragment (TB500) Acetate
01 3U.S.A
02 1Blank
NDC Package Code : 73212-016
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-678
Start Marketing Date : 2021-04-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-313
Start Marketing Date : 2019-06-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82907-988
Start Marketing Date : 2024-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Thymosin Beta-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thymosin Beta-4, including repackagers and relabelers. The FDA regulates Thymosin Beta-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thymosin Beta-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thymosin Beta-4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Thymosin Beta-4 supplier is an individual or a company that provides Thymosin Beta-4 active pharmaceutical ingredient (API) or Thymosin Beta-4 finished formulations upon request. The Thymosin Beta-4 suppliers may include Thymosin Beta-4 API manufacturers, exporters, distributors and traders.
click here to find a list of Thymosin Beta-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Thymosin Beta-4 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Thymosin Beta-4 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Thymosin Beta-4 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Thymosin Beta-4 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Thymosin Beta-4 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Thymosin Beta-4 suppliers with NDC on PharmaCompass.
We have 2 companies offering Thymosin Beta-4
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
